Saturday 17 October 2026
Export COR’s income statement to Excel — free account
Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.
340.66
0.75
−0.22%
Follow COR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 96.34% | 106.98% | 132.25% | 122.67% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 6 | 6 | 6 | |
| 3.33% | 3.33% | 2.20% | 2.16% | ||
ROIC |
15.65% | 12.64% | 20.29% | 32.52% | |
Return on Tangible Assets |
(256.39%) | (1,370.54%) | (64.24%) | (51.08%) | |
Average Days of Receivables |
27.91 | 27.64 | 29.11 | 28.65 | |
Free Cash Flow per Share |
21.26 | 8.23 | 18.79 | 16.55 | |
Free Cash Flow |
4,105.92 | 1,601.89 | 3,650.33 | 3,207.14 | |
Capital Expenditures |
(715.03) | (674.25) | (638.41) | (667.98) | |
| Other line items | |||||
Cash ROIC |
23.10% | 8.83% | 31.01% | 23.30% | |
Accounts Receivable Turnover |
13.31 | 13.52 | 12.90 | 13.09 | |
Accounts Payable Turnover |
6.04 | 6.20 | 5.92 | 5.87 | |
Inventory Turnover |
15.52 | 16.22 | 14.08 | 15.69 | |
Average Days of Payables |
62.48 | 59.90 | 65.21 | 64.46 | |
Days of Inventory on Hand |
24.02 | 23.10 | 28.01 | 24.14 | |
Tax Rate |
(0.27) | (0.27) | (0.30) | (0.31) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.30% | 2.19% | 2.09% | 2.02% | |
Share Based Compensation of Revenue |
0.04% | 0.04% | 0.04% | 0.05% | |
Interest Coverage |
7.05 | 7.49 | 7.98 | 9.02 | |
Operating CF/Net income |
1.84 | 0.89 | 2.64 | 2.49 | |
Depreciation/Fixed assets |
0.38 | 0.37 | 0.43 | 0.42 | |
Capex/Depreciation |
(0.67) | (0.64) | (0.61) | (0.63) | |
Revenue per Share |
1,722.89 | 1,689.48 | 1,677.37 | 1,657.89 | |
Operating CF per Share |
24.96 | 11.70 | 22.08 | 19.99 | |
Capex per Share |
(3.70) | (3.47) | (3.29) | (3.45) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates